Literature DB >> 19508949

Recent developments in the classification and assessment of vasculitis.

Richard A Watts1, David G I Scott.   

Abstract

The systemic vasculitides are a group of multisystem diseases characterized by inflammation of blood vessels. The aetiopathogenesis is unknown, and therefore nomenclature and classification are often descriptive and based on pathological features. Generally agreed classification schemes are vital to enable large multicentre or multinational clinical trials to be undertaken. An algorithm has recently been developed to harmonize use of the American College of Rheumatology (ACR) 1990 criteria and the Chapel Hill Consensus Conference definitions. Despite this, a revision of the classification criteria is still needed, and diagnostic criteria need to be developed ab initio. The very complexity of the diseases makes accurate objective assessment critical, especially for the conduct of clinical trials. Several standardized assessment tools for both disease activity and damage have been developed over the past two decades and are now widely used in both clinical trials and routine practice. A second generation of tools is now under development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508949     DOI: 10.1016/j.berh.2008.12.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  17 in total

Review 1.  Role of ultrasound in the understanding and management of vasculitis.

Authors:  Wolfgang A Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

2.  Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for therapy evaluation of patients with large-vessel vasculitis.

Authors:  Francesco Bertagna; Giovanni Bosio; Federico Caobelli; Federica Motta; Giorgio Biasiotto; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2010-05-01       Impact factor: 2.374

3.  Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer.

Authors:  Humaid O Al-Shamsi; Bryan K Kee; Michael T Tetzlaff; Robert A Wolff
Journal:  J Gastrointest Oncol       Date:  2015-06

Review 4.  Cutting edge issues in the Churg-Strauss syndrome.

Authors:  Wojciech Szczeklik; Bogdan Jakieła; Dariusz Adamek; Jacek Musiał
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

5.  Isolated lower limb medium-vessel vasculitis: a new entity?

Authors:  David Gore; Marwan Bukhari
Journal:  BMJ Case Rep       Date:  2011-06-09

6.  Testicular vasculitis - literature review and case report in queensland.

Authors:  Narelle Lintern; Nigel R Johnson; Ian Mckenzie; Ben Martin
Journal:  Curr Urol       Date:  2013-10-30

Review 7.  Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.

Authors:  Yoshishige Miyabe; Jeffrey Lian; Chie Miyabe; Andrew D Luster
Journal:  Nat Rev Rheumatol       Date:  2019-11-08       Impact factor: 20.543

8.  Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.

Authors:  Mohamad Zaidan; Eric Mariotte; Lionel Galicier; Bertrand Arnulf; Véronique Meignin; Jérôme Vérine; Alfred Mahr; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2012-07-19       Impact factor: 6.925

9.  Vasculitis damage index in Behçet's disease.

Authors:  Fatema T Elgengehy; Sherif M Gamal; Nesreen Sobhy; Ibrahem Siam; Ahmed M Soliman; Ghada W Elhady; Tamer A Gheita
Journal:  Adv Rheumatol       Date:  2021-06-09

Review 10.  Cholinergic anti-inflammatory pathway and connective tissue diseases.

Authors:  Khalil Hajiasgharzadeh; Alireza Khabbazi; Ahad Mokhtarzadeh; Amir Baghbanzadeh; Zahra Asadzadeh; Elham Adlravan; Behzad Baradaran
Journal:  Inflammopharmacology       Date:  2021-06-14       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.